Document is current
Any future updates will be listed below
-
Authors
Hjortdahl, Frederikke
Soendergaard, Marianne Baastrup
Hansen, Susanne
Bjerrum, Anne-Sofie
von Bülow, Anna
Hilberg, Ole
Bonnesen, Barbara
Johnsen, Claus Rikard
Johansson, Sofie Lock
Rasmussen, Linda Makowska
Schmid, Johannes Martin
Ulrik, Charlotte Suppli
Walls, Anne Byriel
Porsbjerg, Celeste
Håkansson, Kjell Erik Julius
-
Funding
Funding for this research was provided by:
Copenhagen University
- License Information
-
More Information
Article History
Received: 22 December 2024
Accepted: 25 February 2025
First Online: 11 March 2025
Declarations
:
: A. von Bülow reports consulting fees from Novartis and AstraZeneca, speaker fees from Novartis, GSK and AstraZeneca, travel grants from AstraZeneca, and participation in advisory boards with AstraZeneca and Novartis. ASB has received personal fees from AstraZeneca, GSK and Sanofi. MBS has received personal fees from GSK, AstraZeneca and ALK-Abello outside of the submitted work. KEJH has received personal fees from AstraZeneca, Chiesi, GSK, Sanofi and TEVA. CSU has received personal fees from AstraZeneca, GSK, TEVA, TFF Pharmaceuticals, Pfizer, Chiesi, Sanofi Genzyme, Boehringer-Ingelheim, Orion Pharma, Novartis, ALK-Abello, Mundipharma and Actelion. CP has received personal fees and research support from AstraZeneca, GSK, Novartis, Sanofi, Teva and ALK. LMR and CRJ none. ABW none. FH none.
